U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07476157) titled 'A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects' on March 12.
Brief Summary: A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 Under Fasted Conditions in Healthy Adult Subjects
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Chronic Heart Failure
Intervention:
DRUG: AD-118, AD-1181
Single-dose oral administration of AD-118 or AD-1181, according to randomized sequence.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Addpharma Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....